Choices of Methodology in Pharmacoeconomic Studies

Autor: Longo, Christopher J.

Publikováno v: Medical Care, 1999 Apr 01. 37(4), AS32-AS35.

Externí odkaz: https://www.jstor.org/stable/3767378

The development process of economic evaluation guidelines in low- and middle-income countries

Autor: Caroline Daccache, Rita Karam, Rana Rizk, Silvia M. A. A. Evers, Mickaël Hiligsmann

Publikováno v: International Journal of Technology Assessment in Health Care. 38(1)

Objectives To review the development of economic evaluation guidelines (EEGs) in low- and middle-income countries (LMICs), with the goal of assisting those developing EEGs in LMICs. Methods We conducted a systematic search in MEDLINE (Ovid), PubMed,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1764be13c3eab344f3bfb402b24796cd
https://doi.org/10.1017/s0266462322000186

What do national pharmacoeconomic guidelines recommend regarding the statistical analysis of trial-based economic evaluations?

Autor: Judith E. Bosmans, Johanna M. van Dongen, Anita N Varga, Angela Jornada Ben, Alejandra E Guevara Morel, Maurits W. van Tulder, Mohamed El Alili, Mojdeh Khorrami

Publikováno v: van Dongen, H, El Alili, M, Varga, A N, Guevara Morel, A E, Jornada Ben, A, Khorrami, M, van Tulder, M W & Bosmans, J E 2020, ' What do national pharmacoeconomic guidelines recommend regarding the statistical analysis of trial-based economic evaluations? ', Expert review of pharmacoeconomics & outcomes research, vol. 20, no. 1, pp. 27-37 . https://doi.org/10.1080/14737167.2020.1694410
van Dongen, J M, El Alili, M, Varga, A N, Guevara Morel, A E, Jornada Ben, A, Khorrami, M, van Tulder, M W & Bosmans, J E 2020, ' What do national pharmacoeconomic guidelines recommend regarding the statistical analysis of trial-based economic evaluations? ', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 20, no. 1, pp. 27-37 . https://doi.org/10.1080/14737167.2020.1694410

Introduction: The statistical quality of many trial-based economic evaluations is poor. When conducting trial-based economic evaluations, researchers often turn to national pharmacoeconomic guidelines for guidance. Therefore, this study reviewed whic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c250754121e10263f12aa90f49c0a63
https://doi.org/10.1080/14737167.2020.1694410

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.